Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
34.44
+0.10 (0.29%)
At close: Nov 14, 2025, 4:00 PM EST
34.34
-0.10 (-0.28%)
After-hours: Nov 14, 2025, 4:15 PM EST

HRTS Holdings Information

HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 10.23%, UnitedHealth Group at 4.41%, Roche Holding AG at 4.38%, AstraZeneca at 4.28%, and Abbott Laboratories at 3.92%.

Total Holdings
25
Top 10 Percentage
44.34%
Asset Class
Equity
ETF Category
Health
Assets
50.11M
PE Ratio
21.19

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company10.23%5,084
2UNHUnitedHealth Group Incorporated4.41%6,577
3RHHBYRoche Holding AG4.38%48,754
4LON: AZNAstraZeneca PLC4.28%12,208
5ABTAbbott Laboratories3.92%15,393
6GILDGilead Sciences, Inc.3.77%15,449
7TMOThermo Fisher Scientific Inc.3.70%3,186
8BSXBoston Scientific Corporation3.51%17,053
9ABBVAbbVie Inc.3.12%6,769
10JNJJohnson & Johnson3.02%7,863
11SWX: NOVNNovartis AG2.94%11,319
12MDTMedtronic plc2.92%15,434
13VRTXVertex Pharmaceuticals Incorporated2.71%3,154
14DHRDanaher Corporation2.64%6,092
15MRKMerck & Co., Inc.2.34%12,963
16CPH: NOVO.BNovo Nordisk A/S2.25%22,809
17REGNRegeneron Pharmaceuticals, Inc.2.18%1,618
18AMGNAmgen Inc.2.15%3,239
19BBIOBridgeBio Pharma, Inc.2.02%15,436
20ARWRArrowhead Pharmaceuticals, Inc.1.97%24,089
21CYTKCytokinetics, Incorporated1.95%14,950
22MCKMcKesson Corporation1.94%1,168
23RVMDRevolution Medicines, Inc.1.82%13,975
24ALNYAlnylam Pharmaceuticals, Inc.1.81%2,019
25BMYBristol-Myers Squibb Company1.79%18,439
Showing 25 of 46 holdings
Subscribe to see the full list
As of Nov 12, 2025